Europe Nuclear Medicine Market

Europe Nuclear Medicine Market by Product Type (Diagnostics and Therapeutics), Application (Cardiology, Neurology, Oncology, and Other Applications), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1136
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 180
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Europe nuclear medicine market size is expected to register a significant CAGR during the forecast period, 2021–2028. Growth of the market is attributed to increased frequency of cancer & heart diseases, as well as the growing need for image-guided treatments and diagnostics.

Europe Nuclear Medicine Market Key Takeaways

Nuclear medicine is a branch of medicine that deals with the use of radioactive substances in illness diagnosis and therapy. Nuclear medicine imaging is "radiology done inside out" or "endoradiology" in that it records radiation emitted from within the body rather than radiation emitted from outside sources such as X-rays. The most frequent imaging modalities in nuclear medicine are single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans.

Certain diseases are diagnosed and treated using nuclear medicine methods. Radiopharmaceuticals are radioactive materials used in these treatments. Hyperthyroidism, thyroid cancer, lymphomas, and cancer-related bone pain are illnesses that can be treated using nuclear medicine treatments.

The Covid-19 has had a beneficial influence on the market. People with cardiovascular problems had the worst hit by the coronavirus. It has resulted in a rise in demand for nuclear medicine, which is highly successful at identifying certain illnesses. The use of nuclear medicines has grown as the necessity for precise diagnosis has increased with the rising number of positive cases. Coronavirus has a lethal effect on the respiratory system, thus nuclear medications can be utilized to treat and diagnose respiratory system disorders.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing intensity of cancer and heart diseases, as well as the growing need for image-guided treatments and diagnostics is expected to fuel the market during the forecast period.
  • Increasing availability of efficient diagnostics and treatment techniques is a key factor propelling the market.
  • High cost of medicines is anticipated to hamper the market growth.
  • Strict laws and restrictions for authorizing new items act as major challenge that can hinder the market expansion during the forecast period.
  • Rising demand from emerging countries, forthcoming radioisotopes, and expanding utilization across neurological applications are expected to offer lucrative opportunities for the market players.

Scope of the Report

The report on the Europe nuclear medicine market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Nuclear Medicine Market - Europe Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Product Type (Diagnostics and Therapeutics), Application (Cardiology, Neurology, Oncology, and Other Applications)

Geographical Scope

Germany, United Kingdom, France, Italy, Spain, and Rest of Europe

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Curium Pharma, Cardinal Health, Advanced Accelerator Applications (Novartis AG), Siemens AG, and GE Healthcare.


Market Segment Insights

The diagnostics segment is projected hold a large market share
On the basis of product type, the Europe nuclear medicine market is bifurcated into diagnostics and therapeutics. It is further segregated into diagnostic and therapeutic items. The diagnostics segment is expected to constitute a key share of the market during the forecast period. In radiopharmaceutical diagnostic methods, single-photon emission computed tomography (SPECT) and PET techniques are being frequently used. Due to its low cost and extensive application, SPECT led the nuclear medicine market in 2019. In addition, leading companies in the nuclear medicine industry are introducing digital SPECT scanners for better diagnostics. SPET is a gamma-ray-based nuclear medicine tomographic imaging method. A SPECT scan is a type of imaging that reveals how blood flows through tissues and organs. It can be used to detect seizures, strokes, stress fractures, infections, and spinal malignancies. For example, spectrum dynamics gained FDA clearance in November 2018 for the VERITON-CT 64 SPECT/CT system, which offers greater picture resolution and a 360-degree multi-detector geometry for high sensitivity. PET is expected to expand at the high rate during the forecast period, owing to the utilization of high-energy waves to create 3D images, whole-body scanning for high accuracy, and the potential to identify chronic disorders including Alzheimer's, cancer, and respiratory ailments.

Europe Nuclear Medicine Market By Product type

The cardiology segment is expected to grow at a rapid pace
On the basis of applications, the Europe nuclear medicine market is segregated into cardiology, neurology, oncology, and other applications. The cardiovascular segment is expected to represent a key share of the market during the forecast period. Cardiology is a medical specialty and a subspecialty of internal medicine that deals with cardiac problems. It includes diseases such as congenital heart defects, coronary artery disease, electrophysiology, heart failure, and valvular heart disease, as well as its diagnosis and treatment. Nuclear imaging is a technique for diagnosing and treating diseases such as heart disease, cancer, and brain problems that involves injecting a small quantity of radioactive particle and measuring the response using external detectors like gamma cameras. According to WHO estimates, 17.9 million people died in 2016 due to cardiovascular disease (CVD). As a result of rising number of cardiac illnesses, the category is projected to drive the market.

Germany is expected to dominate the market
On the basis of regions, the Europe nuclear medicine market is classified as Germany, United Kingdom, France, Italy, Spain, and Rest of Europe. The market of Germany is anticipated to expand at a robust CAGR during the forecast period. Germany is the major market for nuclear medicine in Europe.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nuclear Medicine Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Nuclear Medicine Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Nuclear Medicine Market - Supply Chain
  4.5. Global Nuclear Medicine Market Forecast
     4.5.1. Nuclear Medicine Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Nuclear Medicine Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Nuclear Medicine Market Absolute $ Opportunity
5. Global Nuclear Medicine Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Nuclear Medicine Market Size and Volume Forecast by Applications
     5.3.1. Cardiology Neurology Oncology Other Applications
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Nuclear Medicine Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Nuclear Medicine Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Nuclear Medicine Demand Share Forecast, 2019-2026
7. North America Nuclear Medicine Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Nuclear Medicine Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Nuclear Medicine Market Size and Volume Forecast by Applications
     7.4.1. Cardiology Neurology Oncology Other Applications
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Nuclear Medicine Demand Share Forecast, 2019-2026
8. Latin America Nuclear Medicine Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Nuclear Medicine Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Nuclear Medicine Market Size and Volume Forecast by Applications
     8.4.1. Cardiology Neurology Oncology Other Applications
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Nuclear Medicine Demand Share Forecast, 2019-2026
9. Europe Nuclear Medicine Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Nuclear Medicine Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Nuclear Medicine Market Size and Volume Forecast by Applications
     9.4.1. Cardiology Neurology Oncology Other Applications
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Nuclear Medicine Demand Share Forecast, 2019-2026
10. Asia Pacific Nuclear Medicine Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Nuclear Medicine Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Nuclear Medicine Market Size and Volume Forecast by Applications
     10.4.1. Cardiology Neurology Oncology Other Applications
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Nuclear Medicine Demand Share Forecast, 2019-2026
11. Middle East & Africa Nuclear Medicine Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Nuclear Medicine Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Nuclear Medicine Market Size and Volume Forecast by Applications
     11.4.1. Cardiology Neurology Oncology Other Applications
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Nuclear Medicine Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Nuclear Medicine Market: Market Share Analysis
  12.2. Nuclear Medicine Distributors and Customers
  12.3. Nuclear Medicine Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Curium Pharma Cardinal Health Advanced Accelerator Applications (Novartis AG) Siemens AG GE Healthcare
Segments Covered in the Report
The Europe nuclear medicine market has been segmented on the basis of

Product type
  • Diagnostics
  • Therapeutics
Applications
  • Cardiology
  • Neurology
  • Oncology
  • Other Applications
Geography
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
Key Players
  • Curium Pharma
  • Cardinal Health
  • Advanced Accelerator Applications (Novartis AG)
  • Siemens AG
  • GE Healthcare

Key players competing in the Europe nuclear medicine market include Curium Pharma, Cardinal Health, Advanced Accelerator Applications (Novartis AG), Siemens AG, and GE Healthcare.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Europe Nuclear Medicine Market By Key Players

Buy Report